The Altered Migration and Distribution of Systemically Administered Mesenchymal Stem Cells in Morphine-Treated Recipients
- 13 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Stem Cell Reviews and Reports
- Vol. 17 (4), 1420-1428
- https://doi.org/10.1007/s12015-021-10126-w
Abstract
Mesenchymal stem cells (MSCs) have the ability to migrate to the site of injury or inflammation, and to contribute to the healing process. Since patients treated with MSCs are often users of analgesic drugs, to relieve their uncomfortable pain associated with the tissue disorder, there is a possibility of negative effects of these drugs on the migration of endogenous and exogenous MSCs. Therefore, we tested the impact of acute and chronic treatment with morphine on the migration and organ distribution of exogenous adipose tissue-derived MSCs in mouse models. Firstly, we showed that the incubation of MSCs with morphine significantly reduced the expression of adhesive molecules CD44 (HCAM), CD54 (ICAM-1) and CD106 (VCAM-1) on MSCs. Using a model of systemic administration of MSCs labeled with vital dye PKH26 and by the application of flow cytometry to detect living CD45−PKH26+ cells, we found a decreased number of labeled MSCs in the lung, spleen and bone marrow, and a significantly increased number of MSCs in the liver of morphine-treated recipients. A skin allograft model was used to study the effects of morphine on the migration of exogenous MSCs to the superficial wound. Intraperitoneally administered MSCs migrated preferentially to the wound site, and this migration was significantly decreased in the morphine-treated recipients. The present results showed that morphine significantly influences the distribution of exogenous MSCs in the body, and decreases their migration to the site of injury. Graphical AbstractKeywords
Funding Information
- Ministerstvo Školství, Mládeže a Tělovýchovy (LTAUSA18)
This publication has 34 references indexed in Scilit:
- Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantationJournal of Zhejiang University-SCIENCE B, 2012
- Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusionFrontiers in Immunology, 2012
- Different Facets of Aging in Human Mesenchymal Stem CellsTissue Engineering, Part B: Reviews, 2010
- Time-Dependent Migration of Systemically Delivered Bone Marrow Mesenchymal Stem Cells to the Infarcted HeartCell Transplantation, 2010
- Murine Mesenchymal Stem Cells Exhibit a Restricted Repertoire of Functional Chemokine Receptors: Comparison with HumanPLOS ONE, 2008
- Prolonged Use of High-Dose Morphine Impairs Angiogenesis and Mobilization of Endothelial Progenitor Cells in MiceAnesthesia & Analgesia, 2008
- Delay of cutaneous wound closure by morphine via local blockade of peripheral tachykinin releaseBiochemical Pharmacology, 2007
- Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injuryKidney International, 2007
- Interactions of Chemokines and Chemokine Receptors Mediate the Migration of Mesenchymal Stem Cells to the Impaired Site in the Brain After Hypoglossal Nerve InjuryThe International Journal of Cell Cloning, 2004
- Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following cultureLeukemia, 2003